nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—Hypersomnia—Lisinopril—dilated cardiomyopathy	0.0499	0.0499	CcSEcCtD
Palonosetron—Metabolic acidosis—Furosemide—dilated cardiomyopathy	0.0439	0.0439	CcSEcCtD
Palonosetron—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.0313	0.0313	CcSEcCtD
Palonosetron—Generalised oedema—Lisinopril—dilated cardiomyopathy	0.0219	0.0219	CcSEcCtD
Palonosetron—Glycosuria—Furosemide—dilated cardiomyopathy	0.0214	0.0214	CcSEcCtD
Palonosetron—Gastritis—Spironolactone—dilated cardiomyopathy	0.0205	0.0205	CcSEcCtD
Palonosetron—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.0189	0.0189	CcSEcCtD
Palonosetron—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.0144	0.0144	CcSEcCtD
Palonosetron—Alopecia—Spironolactone—dilated cardiomyopathy	0.0141	0.0141	CcSEcCtD
Palonosetron—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.013	0.013	CcSEcCtD
Palonosetron—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.0128	0.0128	CcSEcCtD
Palonosetron—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.0126	0.0126	CcSEcCtD
Palonosetron—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.0126	0.0126	CcSEcCtD
Palonosetron—Fluid retention—Lisinopril—dilated cardiomyopathy	0.0124	0.0124	CcSEcCtD
Palonosetron—Urinary retention—Furosemide—dilated cardiomyopathy	0.012	0.012	CcSEcCtD
Palonosetron—Discomfort—Spironolactone—dilated cardiomyopathy	0.0117	0.0117	CcSEcCtD
Palonosetron—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.0115	0.0115	CcSEcCtD
Palonosetron—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.0114	0.0114	CcSEcCtD
Palonosetron—Abdominal distension—Furosemide—dilated cardiomyopathy	0.011	0.011	CcSEcCtD
Palonosetron—Somnolence—Spironolactone—dilated cardiomyopathy	0.0101	0.0101	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00982	0.00982	CcSEcCtD
Palonosetron—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00982	0.00982	CcSEcCtD
Palonosetron—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00976	0.00976	CcSEcCtD
Palonosetron—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00945	0.00945	CcSEcCtD
Palonosetron—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00918	0.00918	CcSEcCtD
Palonosetron—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00899	0.00899	CcSEcCtD
Palonosetron—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.0086	0.0086	CcSEcCtD
Palonosetron—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00854	0.00854	CcSEcCtD
Palonosetron—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00838	0.00838	CcSEcCtD
Palonosetron—Gastritis—Lisinopril—dilated cardiomyopathy	0.00836	0.00836	CcSEcCtD
Palonosetron—Eye disorder—Furosemide—dilated cardiomyopathy	0.00814	0.00814	CcSEcCtD
Palonosetron—Tinnitus—Furosemide—dilated cardiomyopathy	0.00812	0.00812	CcSEcCtD
Palonosetron—Pruritus—Spironolactone—dilated cardiomyopathy	0.00805	0.00805	CcSEcCtD
Palonosetron—Angiopathy—Furosemide—dilated cardiomyopathy	0.0079	0.0079	CcSEcCtD
Palonosetron—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00787	0.00787	CcSEcCtD
Palonosetron—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00778	0.00778	CcSEcCtD
Palonosetron—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00778	0.00778	CcSEcCtD
Palonosetron—Erythema—Furosemide—dilated cardiomyopathy	0.00758	0.00758	CcSEcCtD
Palonosetron—Malnutrition—Furosemide—dilated cardiomyopathy	0.00758	0.00758	CcSEcCtD
Palonosetron—Dizziness—Spironolactone—dilated cardiomyopathy	0.00752	0.00752	CcSEcCtD
Palonosetron—Flatulence—Furosemide—dilated cardiomyopathy	0.00747	0.00747	CcSEcCtD
Palonosetron—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00743	0.00743	CcSEcCtD
Palonosetron—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00737	0.00737	CcSEcCtD
Palonosetron—Vomiting—Spironolactone—dilated cardiomyopathy	0.00723	0.00723	CcSEcCtD
Palonosetron—Rash—Spironolactone—dilated cardiomyopathy	0.00717	0.00717	CcSEcCtD
Palonosetron—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00717	0.00717	CcSEcCtD
Palonosetron—Headache—Spironolactone—dilated cardiomyopathy	0.00713	0.00713	CcSEcCtD
Palonosetron—Anaemia—Furosemide—dilated cardiomyopathy	0.00701	0.00701	CcSEcCtD
Palonosetron—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00689	0.00689	CcSEcCtD
Palonosetron—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00687	0.00687	CcSEcCtD
Palonosetron—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00683	0.00683	CcSEcCtD
Palonosetron—Nausea—Spironolactone—dilated cardiomyopathy	0.00676	0.00676	CcSEcCtD
Palonosetron—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00665	0.00665	CcSEcCtD
Palonosetron—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00645	0.00645	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00641	0.00641	CcSEcCtD
Palonosetron—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00641	0.00641	CcSEcCtD
Palonosetron—Dry mouth—Furosemide—dilated cardiomyopathy	0.00631	0.00631	CcSEcCtD
Palonosetron—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00619	0.00619	CcSEcCtD
Palonosetron—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00609	0.00609	CcSEcCtD
Palonosetron—Shock—Furosemide—dilated cardiomyopathy	0.00609	0.00609	CcSEcCtD
Palonosetron—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00607	0.00607	CcSEcCtD
Palonosetron—Skin disorder—Furosemide—dilated cardiomyopathy	0.00601	0.00601	CcSEcCtD
Palonosetron—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00593	0.00593	CcSEcCtD
Palonosetron—Anorexia—Furosemide—dilated cardiomyopathy	0.0059	0.0059	CcSEcCtD
Palonosetron—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00589	0.00589	CcSEcCtD
Palonosetron—Chills—Lisinopril—dilated cardiomyopathy	0.00586	0.00586	CcSEcCtD
Palonosetron—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00584	0.00584	CcSEcCtD
Palonosetron—Hypotension—Furosemide—dilated cardiomyopathy	0.00578	0.00578	CcSEcCtD
Palonosetron—Alopecia—Lisinopril—dilated cardiomyopathy	0.00578	0.00578	CcSEcCtD
Palonosetron—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00573	0.00573	CcSEcCtD
Palonosetron—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00569	0.00569	CcSEcCtD
Palonosetron—Erythema—Lisinopril—dilated cardiomyopathy	0.00569	0.00569	CcSEcCtD
Palonosetron—Flatulence—Lisinopril—dilated cardiomyopathy	0.00561	0.00561	CcSEcCtD
Palonosetron—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00557	0.00557	CcSEcCtD
Palonosetron—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00556	0.00556	CcSEcCtD
Palonosetron—Somnolence—Furosemide—dilated cardiomyopathy	0.0055	0.0055	CcSEcCtD
Palonosetron—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00538	0.00538	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00534	0.00534	CcSEcCtD
Palonosetron—Fatigue—Furosemide—dilated cardiomyopathy	0.00534	0.00534	CcSEcCtD
Palonosetron—Pain—Furosemide—dilated cardiomyopathy	0.00529	0.00529	CcSEcCtD
Palonosetron—Constipation—Furosemide—dilated cardiomyopathy	0.00529	0.00529	CcSEcCtD
Palonosetron—Anaemia—Lisinopril—dilated cardiomyopathy	0.00526	0.00526	CcSEcCtD
Palonosetron—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00506	0.00506	CcSEcCtD
Palonosetron—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00489	0.00489	CcSEcCtD
Palonosetron—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00489	0.00489	CcSEcCtD
Palonosetron—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00484	0.00484	CcSEcCtD
Palonosetron—Myalgia—Lisinopril—dilated cardiomyopathy	0.00484	0.00484	CcSEcCtD
Palonosetron—Anxiety—Lisinopril—dilated cardiomyopathy	0.00483	0.00483	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00481	0.00481	CcSEcCtD
Palonosetron—Discomfort—Lisinopril—dilated cardiomyopathy	0.00479	0.00479	CcSEcCtD
Palonosetron—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00474	0.00474	CcSEcCtD
Palonosetron—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00464	0.00464	CcSEcCtD
Palonosetron—Infection—Lisinopril—dilated cardiomyopathy	0.00461	0.00461	CcSEcCtD
Palonosetron—Shock—Lisinopril—dilated cardiomyopathy	0.00457	0.00457	CcSEcCtD
Palonosetron—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00456	0.00456	CcSEcCtD
Palonosetron—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00453	0.00453	CcSEcCtD
Palonosetron—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00451	0.00451	CcSEcCtD
Palonosetron—Asthenia—Furosemide—dilated cardiomyopathy	0.00444	0.00444	CcSEcCtD
Palonosetron—Anorexia—Lisinopril—dilated cardiomyopathy	0.00443	0.00443	CcSEcCtD
Palonosetron—Pruritus—Furosemide—dilated cardiomyopathy	0.00438	0.00438	CcSEcCtD
Palonosetron—Hypotension—Lisinopril—dilated cardiomyopathy	0.00434	0.00434	CcSEcCtD
Palonosetron—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00423	0.00423	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00423	0.00423	CcSEcCtD
Palonosetron—Insomnia—Lisinopril—dilated cardiomyopathy	0.0042	0.0042	CcSEcCtD
Palonosetron—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00417	0.00417	CcSEcCtD
Palonosetron—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00414	0.00414	CcSEcCtD
Palonosetron—Somnolence—Lisinopril—dilated cardiomyopathy	0.00413	0.00413	CcSEcCtD
Palonosetron—Dizziness—Furosemide—dilated cardiomyopathy	0.00409	0.00409	CcSEcCtD
Palonosetron—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00409	0.00409	CcSEcCtD
Palonosetron—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00404	0.00404	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00401	0.00401	CcSEcCtD
Palonosetron—Fatigue—Lisinopril—dilated cardiomyopathy	0.004	0.004	CcSEcCtD
Palonosetron—Constipation—Lisinopril—dilated cardiomyopathy	0.00397	0.00397	CcSEcCtD
Palonosetron—Pain—Lisinopril—dilated cardiomyopathy	0.00397	0.00397	CcSEcCtD
Palonosetron—Vomiting—Furosemide—dilated cardiomyopathy	0.00393	0.00393	CcSEcCtD
Palonosetron—Rash—Furosemide—dilated cardiomyopathy	0.0039	0.0039	CcSEcCtD
Palonosetron—Dermatitis—Furosemide—dilated cardiomyopathy	0.0039	0.0039	CcSEcCtD
Palonosetron—Headache—Furosemide—dilated cardiomyopathy	0.00388	0.00388	CcSEcCtD
Palonosetron—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.0038	0.0038	CcSEcCtD
Palonosetron—Nausea—Furosemide—dilated cardiomyopathy	0.00368	0.00368	CcSEcCtD
Palonosetron—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00367	0.00367	CcSEcCtD
Palonosetron—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00367	0.00367	CcSEcCtD
Palonosetron—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00342	0.00342	CcSEcCtD
Palonosetron—Asthenia—Lisinopril—dilated cardiomyopathy	0.00333	0.00333	CcSEcCtD
Palonosetron—Pruritus—Lisinopril—dilated cardiomyopathy	0.00329	0.00329	CcSEcCtD
Palonosetron—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00318	0.00318	CcSEcCtD
Palonosetron—Dizziness—Lisinopril—dilated cardiomyopathy	0.00307	0.00307	CcSEcCtD
Palonosetron—Vomiting—Lisinopril—dilated cardiomyopathy	0.00295	0.00295	CcSEcCtD
Palonosetron—Rash—Lisinopril—dilated cardiomyopathy	0.00293	0.00293	CcSEcCtD
Palonosetron—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00293	0.00293	CcSEcCtD
Palonosetron—Headache—Lisinopril—dilated cardiomyopathy	0.00291	0.00291	CcSEcCtD
Palonosetron—Nausea—Lisinopril—dilated cardiomyopathy	0.00276	0.00276	CcSEcCtD
